CYSLTR2 and malignant colon neoplasm: We presumed that the up-regulation of these markers was mediated via a CysLT2/JNK/AP-1 signaling pathway since the induced expression of these proteins could be blocked by the CysLT2 antagonist AP100984 and JNK inhibitor I in both colon cancer cell lines.